FIBRINOGEN - ANVISA Registration 81692610233

Access comprehensive regulatory information for FIBRINOGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81692610233 and manufactured by VYTTRA DIAGNOSTICOS S.A.. The registration is held by VYTTRA DIAGNOSTICOS S.A. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including BIOSYSTEMS S.A., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81692610233
Registration Details
ANVISA Registration Number: 81692610233
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

FIB Test
Risk Class II

Registration Details

81692610233

25351738338202111

00904728001209

Company Information

Brazil
PT: BRASIL

Dates and Status

Jul 22, 2021

VIGENTE

09/18/2025 19:00:01